Worth Venture Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Worth Venture Partners’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,800	Closed	-$640K	–	189
2022 Q2	$640K	Buy	+4,800	New	+$552K	0.38%	69

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Worth Venture Partners's KRTX Position: Q3 2022 in Review

Worth Venture Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2022, closing a stake of 4,800 shares — an estimated $640K sold.

Worth Venture Partners first reported a position in KRTX in Q2 2022 and held it in 1 quarter. The position peaked at $640K in Q2 2022. 257 funds tracked by Wall St. Rank hold KRTX as of Q3 2022.

Worth Venture Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Worth Venture Partners sold 4,800 Karuna Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $640K.
Worth Venture Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Worth Venture Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $640K in Q2 2022.
257 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.